DM
DAWN

Deerfield Management’s Day One Biopharmaceuticals DAWN Stock Holding History

Deerfield Management’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$79.8M Hold
3,723,131
– – 0.94% 34
2025
Q4 		$34.7M Sell
3,723,131
-982,282
-21% -$8.21M 0.44% 46
2025
Q3 		$33.2M Buy
4,705,413
+982,282
+26% +$6.76M 0.51% 46
2025
Q2 		$24.2M Buy
3,723,131
+762,391
+26% +$5.24M 0.44% 46
2025
Q1 		$23.5M Buy
2,960,740
+364,707
+14% +$3.93M 0.46% 45
2024
Q4 		$32.9M Sell
2,596,033
-21,680
-0.8% -$302K 0.62% 39
2024
Q3 		$36.5M Sell
2,617,713
-305,424
-10% -$4.36M 0.54% 43
2024
Q2 		$40.3M Buy
2,923,137
+1,157,825
+66% +$16.9M 0.67% 37
2024
Q1 		$29.2M Buy
1,765,312
+4,134
+0.2% +$61.9K 0.51% 40
2023
Q4 		$25.7M Buy
1,761,178
+491,186
+39% +$5.95M 0.47% 41
2023
Q3 		$15.6M Hold
1,269,992
– – 0.34% 49
2023
Q2 		$15.2M Buy
+1,269,992
New +$16.6M 0.32% 56
2023
Q1 		– Sell
-964,033
Closed -$20.7M – 108
2022
Q4 		$20.7M Sell
964,033
-67,967
-7% -$1.39M 0.43% 60
2022
Q3 		$20.7M Sell
1,032,000
-2,480,123
-71% -$52.7M 0.41% 63
2022
Q2 		$62.9M Buy
3,512,123
+1,425,674
+68% +$14.7M 1.3% 25
2022
Q1 		$20.7M Sell
2,086,449
-116,084
-5% -$1.53M 0.46% 50
2021
Q4 		$37.1M Buy
2,202,533
+491,803
+29% +$10.1M 0.78% 38
2021
Q3 		$40.6M Buy
1,710,730
+891,750
+109% +$21.4M 0.79% 38
2021
Q2 		$18.6M Buy
+818,980
New +$17.1M 0.33% 86

Other funds holding DAWN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Deerfield Management's DAWN Position: Q1 2026 in Review

Deerfield Management held its Day One Biopharmaceuticals (DAWN) position steady in Q1 2026 at 3,723,131 shares worth $79.8M. The position accounts for 0.94% of the portfolio, ranked #34.

Deerfield Management first reported a position in DAWN in Q2 2021 and has held it in 19 quarters since. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

  • Deerfield Management held 3,723,131 shares of Day One Biopharmaceuticals worth $79.8M as of Q1 2026.
  • Deerfield Management left its Day One Biopharmaceuticals share count unchanged in Q1 2026.
  • Day One Biopharmaceuticals made up 0.94% of Deerfield Management's portfolio in Q1 2026, its #34 holding.
  • Deerfield Management first reported a position in Day One Biopharmaceuticals in Q2 2021 and has held it in 19 quarters since.
  • 206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on Deerfield Management's 13F filing for Q1 2026, filed 15 May 2026.